SSRIs and SNRIs: risk of persistent pulmonary hypertension in the newborn
May 16 2010 at 9:16 AM Anonymous
Response to risk of PPH raises 2.5 times
--------------------------------------------------------------------------------
Drug safety advice
SSRIs and SNRIs: risk of persistent pulmonary hypertension in the newborn
Antidepressants: risk of fractures
Carbapenems: concomitant use with valproic acid not recommended
Oral tacrolimus products: measures to reduce the risk of medication errors
Simvastatin: increased risk of myopathy at high dose (80 mg)
Stop press
Panitumumab (Vectibix): serious hypersensitivity reactions
Other information from the MHRA
Patient information leaflet of the month: Durogesic DTrans Transdermal Patch
Download documents:
Drug Safety Update: Volume 3, Issue 10, May 2010 (106Kb)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.